Greenwich Lifesciences Inc • GLSI

Capital at risk.

About Greenwich Lifesciences Inc
Ticker
info
GLSI
Trading on
info
NASDAQ
ISIN
info
US3968791083
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Snehal S. Patel
Headquarters
info
Building 14, Stafford, TX, United States, 77477
Employees
info
4
Website
info
https://greenwichlifesciences.com
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company also develops FLAMINGO-01, which is in Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
Metrics
BasicAdvanced
Market cap
info
$117M
P/E ratio
info
-
EPS
info
-$1.46
Dividend Yield
info
0.00%
Beta
info
2.91
Forward P/E ratio
info
0
EBIDTA
info
$-19.6M
Ex dividend date
info
-
Price & volume
Market cap
info
$117M
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
50.73
Earnings
EPS
info
-$1.46
EPS estimate (current quarter)
info
-$0.36
EPS estimate (next quarter)
info
-$0.34
EBITDA
info
$-19.6M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
2.91
52-week High
info
$14.47
52-week Low
info
$7.78
50-day moving average
info
$9.37
200-day moving average
info
$10.32
Short ratio
info
18.31
Short %
info
23.06%
Management effectiveness
ROE (TTM)
info
-543.43%
ROA (TTM)
info
-254.19%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
13.9M
Float
info
6.6M
Insiders %
info
50.59%
Institutions %
info
9.52%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$45.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.61
-$0.21
-190.48%
Q4 • 24Missed
-$0.25
-$0.24
-4.17%
Q1 • 25Missed
-$0.30
-$0.24
-25.00%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-4M
-∞%
Q2 • 25
$0M
$-4.2M
-∞%
Q3 • 25
NaN%
3.14%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$3.1M
$1.7M
53.94%
Q2 • 25
$3.8M
$1.6M
42.61%
Q3 • 25
21.82%
-3.77%
-21.01%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-2.2M
-
$2.6M
$-2.2M
Q2 • 25
$-2.7M
-
$3.4M
$-2.7M
Q3 • 25
19.62%
-
28.56%
19.62%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Greenwich Lifesciences Inc share?
Collapse

Greenwich Lifesciences Inc shares are currently traded for undefined per share.

How many shares does Greenwich Lifesciences Inc have?
Collapse

Greenwich Lifesciences Inc currently has 13.9M shares.

Does Greenwich Lifesciences Inc pay dividends?
Collapse

No, Greenwich Lifesciences Inc doesn't pay dividends.

What is Greenwich Lifesciences Inc 52 week high?
Collapse

Greenwich Lifesciences Inc 52 week high is $14.47.

What is Greenwich Lifesciences Inc 52 week low?
Collapse

Greenwich Lifesciences Inc 52 week low is $7.78.

What is the 200-day moving average of Greenwich Lifesciences Inc?
Collapse

Greenwich Lifesciences Inc 200-day moving average is $10.32.

Who is Greenwich Lifesciences Inc CEO?
Collapse

The CEO of Greenwich Lifesciences Inc is Snehal S. Patel.

How many employees Greenwich Lifesciences Inc has?
Collapse

Greenwich Lifesciences Inc has 4 employees.

What is the market cap of Greenwich Lifesciences Inc?
Collapse

The market cap of Greenwich Lifesciences Inc is $117M.

What is the P/E of Greenwich Lifesciences Inc?
Collapse

The current P/E of Greenwich Lifesciences Inc is null.

What is the EPS of Greenwich Lifesciences Inc?
Collapse

The EPS of Greenwich Lifesciences Inc is -$1.46.

What is the PEG Ratio of Greenwich Lifesciences Inc?
Collapse

The PEG Ratio of Greenwich Lifesciences Inc is null.

What do analysts say about Greenwich Lifesciences Inc?
Collapse

According to the analysts Greenwich Lifesciences Inc is considered a buy.